formulated a nanoliposomal formulation containing siRNA targeting the BCL-2 gene and studied its effect in estrogen receptor (−) MDA-MB-231 and estrogen receptor (+) MCF-7 breast tumor xenograft models. Here, ESR1 is linked to breast neoplasm.